Literature DB >> 10623565

Activation of the small G protein Rap1 in dog thyroid cells by both cAMP-dependent and -independent pathways.

S Dremier1, F Vandeput, F J Zwartkruis, J L Bos, J E Dumont, C Maenhaut.   

Abstract

Thyrotropin, through a cAMP-dependent pathway, stimulates function, differentiation, and proliferation of dog and human thyroid cells. Our previous findings suggested that, in addition to PKA activation, another cAMP-dependent mechanism is involved in TSH action. In this work, we assess whether the newly identified cAMP-Epac-Rap1 cascade is involved in TSH-cAMP-mediated effects in dog thyroid cells. We first demonstrate that TSH and forskolin strongly activate Rap1 in a PKA-independent manner. However, activation of Rap1 is not specific for TSH or cAMP. Indeed, carbachol, TPA, insulin, or EGF, which activate different cAMP-independent cascades, all independently activate Rap1. Rap1 is therefore a common step in all these cascades which exert various effects on proliferation, differentiation, and function of thyroid cells. Moreover, the microinjection of the Rap1 protein alone or in combination with the catalytic C subunit of PKA fails to induce proliferation or expression of thyroglobulin. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10623565     DOI: 10.1006/bbrc.1999.1919

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  HMG-CoA reductase inhibitors inhibit rat propylthiouracil-induced goiter by modulating the ras-MAPK pathway.

Authors:  Chiara Laezza; Gherardo Mazziotti; Laura Fiorentino; Patrizia Gazzerro; Giuseppe Portella; Diego Gerbasio; Carlo Carella; Giuseppe Matarese; Maurizio Bifulco
Journal:  J Mol Med (Berl)       Date:  2006-09-01       Impact factor: 4.599

2.  Switch in signaling control of mTORC1 activity after oncoprotein expression in thyroid cancer cell lines.

Authors:  Roberta Malaguarnera; Kuen-Yuan Chen; Tae-Yong Kim; Jose M Dominguez; Francesca Voza; Bin Ouyang; Sushil K Vundavalli; Jeffrey A Knauf; James A Fagin
Journal:  J Clin Endocrinol Metab       Date:  2014-07-16       Impact factor: 5.958

3.  Neuroprotective role of prostaglandin PGE2 EP2 receptor in hemin-mediated toxicity.

Authors:  Shekher Mohan; Shuh Narumiya; Sylvain Doré
Journal:  Neurotoxicology       Date:  2014-11-13       Impact factor: 4.294

4.  Coordinated regulation of Rap1 and thyroid differentiation by cyclic AMP and protein kinase A.

Authors:  O M Tsygankova; A Saavedra; J F Rebhun; L A Quilliam; J L Meinkoth
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

5.  Effect of long- and short-chain perfluorinated compounds on cultured thyroid cells viability and response to TSH.

Authors:  L Croce; F Coperchini; M Tonacchera; M Imbriani; M Rotondi; L Chiovato
Journal:  J Endocrinol Invest       Date:  2019-05-17       Impact factor: 4.256

6.  Neutral antibodies to the TSH receptor are present in Graves' disease and regulate selective signaling cascades.

Authors:  Syed A Morshed; Takao Ando; Rauf Latif; Terry F Davies
Journal:  Endocrinology       Date:  2010-09-15       Impact factor: 4.736

7.  On the mitogenic properties of Rap1b: cAMP-induced G(1)/S entry requires activated and phosphorylated Rap1b.

Authors:  Fernando Ribeiro-Neto; Julie Urbani; Nicolas Lemee; Liguang Lou; Daniel L Altschuler
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

8.  Cyclic AMP-mediated inhibition of cell growth requires the small G protein Rap1.

Authors:  J M Schmitt; P J Stork
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

9.  Characterization of thyrotropin receptor antibody-induced signaling cascades.

Authors:  Syed A Morshed; Rauf Latif; Terry F Davies
Journal:  Endocrinology       Date:  2008-08-21       Impact factor: 4.736

10.  Protein kinase A and B-Raf mediate extracellular signal-regulated kinase activation by thyrotropin.

Authors:  Lisa A Vuchak; Oxana M Tsygankova; Gregory V Prendergast; Judy L Meinkoth
Journal:  Mol Pharmacol       Date:  2009-08-31       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.